Svingos A L, Clarke C L, Pickel V M
Weill Medical College of Cornell University, Department of Neurology and Neuroscience, Division of Neurobiology, New York, New York 10021, USA.
Synapse. 1999 Oct;34(1):1-10. doi: 10.1002/(SICI)1098-2396(199910)34:1<1::AID-SYN1>3.0.CO;2-H.
Opiate- and psychostimulant-induced modulation of dopamine transmission in the nucleus accumbens shell (AcbSh) is thought to play a key role in their potent reinforcing and locomotor effects. To investigate the cellular basis for potential functional interactions involving opiates active at the delta-opioid receptor (DOR) and psychostimulants that bind selectively to the dopamine transporter (DAT), we examined the electron microscopic localization of their respective antisera in rat AcbSh. DOR immunoperoxidase labeling was seen primarily, and DAT immunogold particles exclusively, in axon terminals. In these terminals, DOR immunoreactivity was prominently associated with discrete segments of the plasma membrane and the membranes of nearby small synaptic and large dense core vesicles. DAT immunogold particles were almost exclusively distributed along nonsynaptic axonal plasma membranes. Thirty-nine percent DOR-labeled profiles (221/566) either apposed DAT-immunoreactive terminals or also contained DAT. Of these 221 DOR-labeled profiles, 13% were axon terminals containing DAT and 15% were dendritic spines apposed to DAT-immunoreactive terminals. In contrast, 70% were morphologically heterogeneous axon terminals and small axons apposed to DAT-immunoreactive terminals. Our results indicate that DOR agonists in the AcbSh can directly modulate the release of dopamine, as well as postsynaptic responses in spiny neurons that receive dopaminergic input, but act principally to control the presynaptic secretion of other neurotransmitters whose release may influence or be influenced by extracellular dopamine. Thus, while opiates and psychostimulants mainly have differential sites of action, cross-sensitization of their addictive properties may occur through common neuronal targets.
阿片类药物和精神兴奋剂对伏隔核壳(AcbSh)中多巴胺传递的调节作用,被认为在它们强大的强化和运动效应中起着关键作用。为了研究涉及δ-阿片受体(DOR)活性阿片类药物和选择性结合多巴胺转运体(DAT)的精神兴奋剂之间潜在功能相互作用的细胞基础,我们在大鼠AcbSh中检查了它们各自抗血清的电子显微镜定位。DOR免疫过氧化物酶标记主要见于轴突终末,而DAT免疫金颗粒仅见于轴突终末。在这些终末中,DOR免疫反应性与质膜的离散节段以及附近小突触囊泡和大致密核心囊泡的膜显著相关。DAT免疫金颗粒几乎完全沿着非突触性轴突质膜分布。39%的DOR标记轮廓(221/566)要么与DAT免疫反应性终末相邻,要么也含有DAT。在这221个DOR标记轮廓中,13%是含有DAT的轴突终末,15%是与DAT免疫反应性终末相邻的树突棘。相比之下,70%是形态学上异质性的轴突终末和与DAT免疫反应性终末相邻的小轴突。我们的结果表明,AcbSh中的DOR激动剂可以直接调节多巴胺的释放,以及接受多巴胺能输入的棘状神经元的突触后反应,但主要作用是控制其他神经递质的突触前分泌,这些神经递质的释放可能会影响细胞外多巴胺或受其影响。因此,虽然阿片类药物和精神兴奋剂主要有不同的作用位点,但它们成瘾特性的交叉致敏可能通过共同的神经元靶点发生。